Using point-of-care lung ultrasound to explore how TB severity affects people’s socio-economic status

Point-Of-Care Ultrasound for Tuberculosis Formative Prospective case-control study with nested cohort in Bolivia: characterising associations between disease severity and the socioeconomic consequences of TB

Registry ID
ISRCTN87512724
Source registry
ISRCTN
Status
Recruiting
Study type
OBSERVATIONAL
Sponsor
London School of Hygiene & Tropical Medicine
Enrollment
300
Start date
2026-03-17
Completion date
2027-03-31
Last update
2026-08-17

Conditions

Summary

Tuberculosis

Detailed description

This is a 2:1 case-control study, in which adults recently diagnosed with TB attending a health care facility will be invited to participate (cases), as well as adults randomly selected from the community (controls). Baseline Visit: After obtaining informed consent, participants will undergo interviews to assess socioeconomic status, and a physical examination, including measurements such as weight and height, will be conducted together with a point-of-care ultrasound (POCUS). Clinical data will be collected from participants´ records. Follow-up Visits: Follow-up visits will be conducted only for participants diagnosed with TB (cases) at 2 and 6 months post-treatment, with repeat interviews to assess socioeconomic status, physical examination and measures, data collection from medical records and POCUS. The study will focus on using POCUS to better understand TB disease severity and its socioeconomic impact. POCUS images will also be used to train an AI model that could improve TB screening and triage in the future.

Interventions

Inclusion criteria

For participants diagnosed with TB (cases): 1. Aged ≥18 years old 2. Receiving or will receive treatment for pulmonary TB at the selected health centre For community controls: 1. Aged ≥18 years old 2. Resides in the selected community

Exclusion criteria

For participants diagnosed with TB (cases): 1. Started treatment >2 weeks for the current TB episode 2. Refusing to provide informed consent/assent to participate in the study For community controls: 1. Received TB treatment <1 year ago 2. Refusing to provide informed consent/assent to participate in the study 3. Serious illness resulting in unstable condition or life-threatening participation in the study

Locations

Related clinical trials

View on source registry